[HTML][HTML] Targeting neuroinflammation in Alzheimer's disease: From mechanisms to clinical applications

ZZ Si, CJ Zou, X Mei, XF Li, H Luo, Y Shen… - Neural regeneration …, 2023 - journals.lww.com
Alzheimer's disease is characterized by sustained neuroinflammation leading to memory
loss and cognitive decline. The past decade has witnessed tremendous efforts in …

Pharmacological inhibition of the NLRP3 inflammasome: structure, molecular activation, and inhibitor-NLRP3 interaction

Q Ma - Pharmacological reviews, 2023 - ASPET
The nucleotide-binding, oligomerization domain-like receptor family pyrin domain containing
3 (NLRP3) inflammasome is a multiprotein complex that combines sensing, regulation, and …

[HTML][HTML] Involvement of inflammasomes in tumor microenvironment and tumor therapies

Z Zhang, X Li, Y Wang, Y Wei, X Wei - Journal of Hematology & Oncology, 2023 - Springer
Inflammasomes are macromolecular platforms formed in response to damage-associated
molecular patterns (DAMPs) and pathogen-associated molecular patterns, whose formation …

[HTML][HTML] The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors

X Zhan, Q Li, G Xu, X Xiao, Z Bai - Frontiers in Immunology, 2023 - frontiersin.org
NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3) is a cytosolic pattern
recognition receptor (PRR) that recognizes multiple pathogen-associated molecular patterns …

Disruptions in endocytic traffic contribute to the activation of the NLRP3 inflammasome

B Lee, C Hoyle, R Wellens, JP Green… - Science …, 2023 - science.org
Inflammation driven by the NLRP3 inflammasome is coordinated through multiple signaling
pathways and is regulated by subcellular organelles. Here, we tested the hypothesis that …

Targeting NLRP3 inflammasome for neurodegenerative disorders

J Yao, Z Wang, W Song, Y Zhang - Molecular psychiatry, 2023 - nature.com
Neuroinflammation is a key pathological feature in neurological diseases, including
Alzheimer's disease (AD). The nucleotide-binding domain leucine-rich repeat-containing …

[HTML][HTML] The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy

X Zheng, J Wan, G Tan - Frontiers in Immunology, 2023 - frontiersin.org
In the working-age population worldwide, diabetic retinopathy (DR), a prevalent
complication of diabetes, is the main cause of vision impairment. Chronic low-grade …

Mechanistic and therapeutic role of NLRP3 inflammasome in the pathogenesis of Alzheimer's disease

D Jha, ENTP Bakker, R Kumar - Journal of neurochemistry, 2023 - Wiley Online Library
Abstract Alzheimer's disease (AD), a progressive neurodegenerative disorder, has emerged
as the most common form of dementia in the elderly. Several pathological hallmarks have …

[HTML][HTML] Portrayal of NLRP3 inflammasome in atherosclerosis: current knowledge and therapeutic targets

DM Tanase, E Valasciuc, EM Gosav, A Ouatu… - International Journal of …, 2023 - mdpi.com
We are witnessing the globalization of a specific type of arteriosclerosis with rising
prevalence, incidence and an overall cardiovascular disease burden. Currently …

[HTML][HTML] TNEA therapy promotes the autophagic degradation of NLRP3 inflammasome in a transgenic mouse model of Alzheimer's disease via TFEB/TFE3 activation

W Lin, Z Li, G Liang, R Zhou, X Zheng, R Tao… - Journal of …, 2023 - Springer
Background The impairment in the autophagy-lysosomal pathway (ALP) and the activation
of NLR family pyrin domain containing 3 (NLRP3) inflammasome represent two molecular …